Press Releases



October 28, 2021 — PRESS RELEASE

Latest Clinical Evidence Presented at SAWC 2021 Illustrates the Significant Clinical Utility of the MolecuLight Point-of-Care Imaging Platform

October 19, 2021 — PRESS RELEASE

Joerns Healthcare Introduces Point-of-Care Imaging to Wound Care Portfolio Through MolecuLight Partnership

October 14, 2021 — PRESS RELEASE

Launch of New MolecuLightDX™ Device to Enable Point-of-Care Imaging of Wounds in New Expanding Market Segments

October 12, 2021 — PRESS RELEASE

Study of 236 patients reveals utility of MolecuLight i:X® in detection and management of wound-related cellulitis

September 23, 2021 — PRESS RELEASE

MolecuLight i:X® Receives FDA 510(k) Clearance for the Device’s Ability to Detect Wounds Likely to Contain Pseudomonas Aeruginosa (PA)

July 7, 2021 — PRESS RELEASE

In new publication, 96% of clinicians state that treatment plans informed using the MolecuLight procedure led to improved wound healing – MolecuLight US

June 22, 2021 — PRESS RELEASE

MolecuLight Signs LMT Surgical as New Distributor for Australia and New Zealand

May 18, 2021 — PRESS RELEASE

Novel Technology to Help Improve Wound Care in Canada Enabled Through CAN Health, Sunnybrook and MolecuLight Collaboration

May 6, 2021 — PRESS RELEASE

MolecuLight Announces Integration of its i: Fluorescence Imaging Device with Net Health’s Tissue Analytics API Program

May 4, 2021 — PRESS RELEASE

MolecuLight Receives Innovative Technology Contract from Vizient for its i:X® Fluorescence Wound Imaging Device

April 8, 2021 — PRESS RELEASE

MolecuLight Announces the Appointment of 11 Global Distributors

March 9, 2021 — PRESS RELEASE

MolecuLight i:X® Platform Available to 650 Long-Term Healthcare Facilities Through Synergy HealthCare Alliance, LLC

March 2, 2021 — PRESS RELEASE

Results Published in Study Show MolecuLight Fluorescence Point-of-Care Imaging Detected Pseudomonas Aeruginosa (PA) in Wounds with a PPV of 93%


December 10, 2020 — PRESS RELEASE

Wound Care Plus, LLC Adopts the MolecuLight i:X® as a Standard Point-of-Care Device for its Wound Care Service Offering to the Long-Term Care and Extended Care Markets

November 25, 2020 — PRESS RELEASE

Results Published from 2-Year Study of 229 Wounds Treated in an NHS Clinic Show Fluorescence Point-of-Care Imaging Improved Wound Healing Rates by 23%

September 29, 2020 — PRESS RELEASE

Results from 350-Patient FLAAG Trial Show MolecuLight Point-of-Care Imaging Improves Detection of High Bacterial Burden in Wounds Four-fold over Standard of Care Assessment

August 12, 2020 — PRESS RELEASE

MolecuLight Announces Availability of its MolecuLight i:X® Platform on Epic’s App Orchard

July 9, 2020 — PRESS RELEASE

MolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting

June 15, 2020 — PRESS RELEASE

MolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO

June 11, 2020 — PRESS RELEASE

MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence

April 1, 2020 — PRESS RELEASE

MolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ 2020, the Largest Conference for Wound Care

March 3, 2020 — PRESS RELEASE

First Published Study to Report In Vitro Detection of Fluorescence from Bacteria in Biofilm with Point-of-care Wound Imaging Device

February 20, 2020 — PRESS RELEASE

New MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement

February 13, 2020 — PRESS RELEASE

American Medical Association Issues Category lll CPT Code for Real-time Fluorescence Wound Imaging

February 11, 2020 — PRESS RELEASE

University Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging Device in Clinical Setting